Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial

DSpace Repository

Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial

Author: Schmoll, Hans-Joachim; Wittig, Burghardt; Arnold, Dirk; Riera-Knorrenschild, Jorge; Nitsche, Dieter; Kroening, Hendrik; Mayer, Frank; Andel, Johannes; Ziebermayr, Reinhard; Scheithauer, Werner
Tübinger Autor(en):
Mayer, Frank
Published in: Journal of Cancer Research and Clinical Oncology (2014), Bd. 140, H. 9, S. 1615-1624
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s00432-014-1682-7
ISSN: 0171-5216
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)